Inventor
GIANNESSI FABIO
IT22 patents
Patents
22 patentsUS6369073B1Apr 9, 2002
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI95 citations96
US6444701B1Sep 3, 2002
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI19 citations91
US5491260AFeb 13, 1996
Process for manufacturing L-(-)-carnitine from derivatives having a configuration opposite to that of L-(-)-carnitine
SIGMA TAU IND FARMACEUTI9 citations72
US6822115B2Nov 23, 2004
Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid
SIGMA TAU IND FARMACEUTI8 citations71
US6528684B1Mar 4, 2003
Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid
SIGMA TAU IND FARMACEUTI10 citations71
US5412113AMay 2, 1995
Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI10 citations71
US5155102AOct 13, 1992
1-alkyl-3-(acylamino)-ε-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same
SIGMA TAU IND FARMACEUTI9 citations71
US5061725AOct 29, 1991
(pyrrolidin-2-one-1-yl) acetamides and enhancers of learning and memory pharmaceutical compositions comprising same
SIGMA TAU IND FARMACEUTI9 citations70
US6127552AOct 3, 2000
Process for producing (R)-3-hydroxy-4-butyrolactone useful for preparing (R)-carnitine
SIGMA TAU IND FARMACEUTI2 citations62
US5714619AFeb 3, 1998
Process for the preparation of (S)-β-hydroxy-γ-butyrolactone
SIGMA TAU IND FARMACEUTI2 citations62
USRE41226EApr 13, 2010
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI1 citations61
USRE40861EJul 21, 2009
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
SIGMA TAU IND FARMACEUTI1 citations61
US5532409AJul 2, 1996
Process for producing R-aminocarnitine and S-aminocarnitine
SIGMA TAU IND FARMACEUTI5 citations61
US5102896AApr 7, 1992
1-acyl-2-pyrrolidinones as enhancers of learning and memory
SIGMA TAU IND FARMACEUTI2 citations61
US5599978AFeb 4, 1997
Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI4 citations60
US5532410AJul 2, 1996
Process for manufacturing L(-)-carnitine from a waste product having opposite configuration
SIGMA TAU IND FARMACEUTI4 citations59
US6316667B2Nov 13, 2001
Process for the preparation of R-(-)-carnitine
SIGMA TAU IND FARMACEUTI0 citations52
US5227496AJul 13, 1993
Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same
SIGMA TAU IND FARMACEUTI0 citations50
US5192759AMar 9, 1993
Derivatives of 1,2,3,4-tetrahydronaphtylamine endowed with nootropic activity and pharmaceutical compositions containing same
SIGMA TAU IND FARMACEUTI0 citations50
US5166150ANov 24, 1992
Pharmaceutical compositions comprising 3-amino-ε-caprolactames for enhancing the process of learning and memory
SIGMA TAU IND FARMACEUTI0 citations50
US7375124B2May 20, 2008
Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
SIGMA TAU IND FARMACEUTI0 citations40
US7368605B2May 6, 2008
Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
SIGMA TAU IND FARMACEUTI0 citations33